These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 37373186)

  • 21. Predicting drug-target interaction network using deep learning model.
    You J; McLeod RD; Hu P
    Comput Biol Chem; 2019 Jun; 80():90-101. PubMed ID: 30939415
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Exploration of active components and mechanism of Scutellariae Radix-Phellodendri Chinensis Cortex drug pair in treatment of psoriasis based on network pharmacology and molecular docking].
    Ma BZ; Li D; Wang HY; Tang YH; Bai D; He J; Liu X
    Zhongguo Zhong Yao Za Zhi; 2021 Oct; 46(20):5330-5340. PubMed ID: 34738437
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identification of candidate biomarkers and pathways associated with psoriasis using bioinformatics analysis.
    Luo Y; Luo Y; Chang J; Xiao Z; Zhou B
    Hereditas; 2020 Jul; 157(1):30. PubMed ID: 32669126
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Repositioning drugs by targeting network modules: a Parkinson's disease case study.
    Yue Z; Arora I; Zhang EY; Laufer V; Bridges SL; Chen JY
    BMC Bioinformatics; 2017 Dec; 18(Suppl 14):532. PubMed ID: 29297292
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Genetic-and-Epigenetic Interspecies Networks for Cross-Talk Mechanisms in Human Macrophages and Dendritic Cells during MTB Infection.
    Li CW; Lee YL; Chen BS
    Front Cell Infect Microbiol; 2016; 6():124. PubMed ID: 27803888
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Novel factors in the pathogenesis of psoriasis and potential drug candidates are found with systems biology approach.
    Manczinger M; Kemény L
    PLoS One; 2013; 8(11):e80751. PubMed ID: 24303025
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Transcriptional regulatory network for psoriasis.
    Lu X; Du J; Liang J; Zhu X; Yang Y; Xu J
    J Dermatol; 2013 Jan; 40(1):48-53. PubMed ID: 23078099
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identification of Novel Hub Genes Associated with Psoriasis Using Integrated Bioinformatics Analysis.
    Yue Q; Li Z; Zhang Q; Jin Q; Zhang X; Jin G
    Int J Mol Sci; 2022 Dec; 23(23):. PubMed ID: 36499614
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Molecular mechanisms of Biyu decoction as treatment for psoriasis: A network pharmacology and molecular docking study.
    Wang Z; Zhang HM; Guo YR; Li LL
    World J Clin Cases; 2022 Jul; 10(21):7224-7241. PubMed ID: 36158000
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Decoding Psoriasis: Integrated Bioinformatics Approach to Understand Hub Genes and Involved Pathways.
    Choudhary S; Pradhan D; Khan NS; Singh H; Thomas G; Jain AK
    Curr Pharm Des; 2020; 26(29):3619-3630. PubMed ID: 32160841
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Deciphering the pharmacological mechanism of the Chinese formula huanglian-jie-du decoction in the treatment of ischemic stroke using a systems biology-based strategy.
    Zhang YQ; Wang SS; Zhu WL; Ma Y; Zhang FB; Liang RX; Xu HY; Yang HJ
    Acta Pharmacol Sin; 2015 Jun; 36(6):724-33. PubMed ID: 25937634
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identifying Novel Psoriatic Disease Drug Targets Using a Genetics-Based Priority Index Pipeline.
    Bui A; Liu J; Hong J; Hadeler E; Mosca M; Brownstone N; Liao W
    J Psoriasis Psoriatic Arthritis; 2021 Oct; 6(4):185-197. PubMed ID: 35756599
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Repurposing an old drug for new use: Niclosamide in psoriasis-like skin inflammation.
    Thatikonda S; Pooladanda V; Godugu C
    J Cell Physiol; 2020 Jun; 235(6):5270-5283. PubMed ID: 31846070
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Deciphering crucial genes in multiple sclerosis pathogenesis and drug repurposing: A systems biology approach.
    Dadashkhan S; Mirmotalebisohi SA; Poursheykhi H; Sameni M; Ghani S; Abbasi M; Kalantari S; Zali H
    J Proteomics; 2023 May; 280():104890. PubMed ID: 36966969
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.
    Sbidian E; Chaimani A; Garcia-Doval I; Do G; Hua C; Mazaud C; Droitcourt C; Hughes C; Ingram JR; Naldi L; Chosidow O; Le Cleach L
    Cochrane Database Syst Rev; 2017 Dec; 12(12):CD011535. PubMed ID: 29271481
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.
    Sbidian E; Chaimani A; Garcia-Doval I; Doney L; Dressler C; Hua C; Hughes C; Naldi L; Afach S; Le Cleach L
    Cochrane Database Syst Rev; 2021 Apr; 4(4):CD011535. PubMed ID: 33871055
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A computational multi-targeting approach for drug repositioning for psoriasis treatment.
    Ibezim A; Onah E; Dim EN; Ntie-Kang F
    BMC Complement Med Ther; 2021 Jul; 21(1):193. PubMed ID: 34225727
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Integrated bioinformatic analysis of differentially expressed genes and signaling pathways in plaque psoriasis.
    Zhang YJ; Sun YZ; Gao XH; Qi RQ
    Mol Med Rep; 2019 Jul; 20(1):225-235. PubMed ID: 31115544
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Network analysis of psoriasis reveals biological pathways and roles for coding and long non-coding RNAs.
    Ahn R; Gupta R; Lai K; Chopra N; Arron ST; Liao W
    BMC Genomics; 2016 Oct; 17(1):841. PubMed ID: 27793094
    [TBL] [Abstract][Full Text] [Related]  

  • 40. CXCL10 and its related key genes as potential biomarkers for psoriasis: Evidence from bioinformatics and real-time quantitative polymerase chain reaction.
    Zou A; Jian Q
    Medicine (Baltimore); 2021 Sep; 100(38):e27365. PubMed ID: 34559160
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.